Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
Euronews (English) on MSN21h
AstraZeneca reports strong results boosted by promising trialsAstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...
AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...
GlobalData on MSN19h
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trialResearchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback